In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Flutrimazole Drug Master File in Korea (Flutrimazole KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flutrimazole. The MFDS reviews the Flutrimazole KDMF as part of the drug registration process and uses the information provided in the Flutrimazole KDMF to evaluate the safety and efficacy of the drug.
After submitting a Flutrimazole KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flutrimazole API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Flutrimazole suppliers with KDMF on PharmaCompass.